DK3269386T3 - Aluminiumforbindelser til anvendelse inden for behandling og i vacciner - Google Patents
Aluminiumforbindelser til anvendelse inden for behandling og i vacciner Download PDFInfo
- Publication number
- DK3269386T3 DK3269386T3 DK17185526.5T DK17185526T DK3269386T3 DK 3269386 T3 DK3269386 T3 DK 3269386T3 DK 17185526 T DK17185526 T DK 17185526T DK 3269386 T3 DK3269386 T3 DK 3269386T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccines
- treatment
- aluminum compounds
- aluminum
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11192230 | 2011-12-06 | ||
PCT/EP2012/054387 WO2013135274A1 (en) | 2012-03-13 | 2012-03-13 | Aluminium compounds for use in therapeutics and vaccines |
EP16183076.5A EP3106176B1 (en) | 2011-12-06 | 2012-12-06 | Aluminium compounds for use in therapeutics and vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3269386T3 true DK3269386T3 (da) | 2022-10-24 |
Family
ID=47294919
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12795830.4T DK2788023T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner |
DK16183076.5T DK3106176T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutika og vacciner |
DK20184308.3T DK3785730T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner |
DK17185526.5T DK3269386T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse inden for behandling og i vacciner |
DKBA201300194U DK201300194U1 (da) | 2011-12-06 | 2013-12-09 | Aluminiumhydroxidkoncentrat, fortrinsvis til anvendelse i fremstillingen af en vaccine |
DKBA201300193U DK201300193U1 (da) | 2011-12-06 | 2013-12-09 | Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner. |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12795830.4T DK2788023T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner |
DK16183076.5T DK3106176T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutika og vacciner |
DK20184308.3T DK3785730T3 (da) | 2011-12-06 | 2012-12-06 | Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DKBA201300194U DK201300194U1 (da) | 2011-12-06 | 2013-12-09 | Aluminiumhydroxidkoncentrat, fortrinsvis til anvendelse i fremstillingen af en vaccine |
DKBA201300193U DK201300193U1 (da) | 2011-12-06 | 2013-12-09 | Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner. |
Country Status (15)
Country | Link |
---|---|
EP (5) | EP3106176B1 (da) |
CY (1) | CY1119927T1 (da) |
DE (1) | DE202012012768U1 (da) |
DK (6) | DK2788023T3 (da) |
ES (2) | ES2930458T3 (da) |
FI (1) | FI3785730T3 (da) |
HR (1) | HRP20171871T1 (da) |
HU (1) | HUE037325T2 (da) |
LT (1) | LT3106176T (da) |
NO (1) | NO3106176T3 (da) |
PL (2) | PL3269386T3 (da) |
PT (2) | PT3269386T (da) |
RS (1) | RS56709B1 (da) |
SI (1) | SI3106176T1 (da) |
WO (1) | WO2013083726A1 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2788023T3 (da) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner |
US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
MX2017002803A (es) | 2014-09-03 | 2017-06-09 | Intervet Int Bv | Coronavirus bovino atenuado y vacunas relacionadas. |
WO2017109225A1 (en) | 2015-12-23 | 2017-06-29 | Valneva Austria Gmbh | Zika virus vaccine |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
CN118662649A (zh) | 2016-12-30 | 2024-09-20 | Vaxcyte公司 | 具有非天然氨基酸的多肽-抗原缀合物 |
ES2957939T3 (es) | 2017-04-13 | 2024-01-30 | Valneva Austria Gmbh | Polipéptidos de OspA multivalentes y métodos y usos relacionados con los mismos |
JP7301811B2 (ja) | 2017-09-21 | 2023-07-03 | ヴァルネヴァ エスイー | 免疫原性チクングニアウイルスchikv-delta 5nsp3を含む医薬組成物を製造する方法 |
CN111511395B (zh) | 2017-11-03 | 2024-10-15 | 武田疫苗股份有限公司 | 用于将寨卡病毒灭活和用于确定灭活完全性的方法 |
JP2021505549A (ja) | 2017-11-30 | 2021-02-18 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | ジカワクチン及び免疫原性組成物、ならびにその使用方法 |
CA3106286A1 (en) | 2018-07-13 | 2020-01-16 | Valneva Se | Method for rescuing and producing a virus in avian cells |
CA3138064A1 (en) | 2019-05-20 | 2020-11-26 | Valneva Se | A subunit vaccine for treatment or prevention of a respiratory tract infection |
WO2021178306A1 (en) * | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
WO2021176434A1 (en) | 2020-03-01 | 2021-09-10 | Valneva Austria Gmbh | Cpg-adjuvanted sars-cov-2 virus vaccine |
EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
WO2021178318A1 (en) * | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
MX2022010642A (es) * | 2020-03-01 | 2022-11-08 | Dynavax Tech Corp | Vacunas contra coronavirus que comprenden un agonista de tlr9. |
WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
CA3174599A1 (en) | 2020-04-09 | 2021-10-14 | Robert Schlegl | Improvements in vaccine formulations for medical use |
AU2022255923A1 (en) | 2021-04-09 | 2023-08-31 | Valneva Se | Human metapneumo virus vaccine |
WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
WO2023232901A1 (en) | 2022-06-01 | 2023-12-07 | Valneva Austria Gmbh | Clostridium difficile vaccine |
WO2024153686A1 (en) | 2023-01-18 | 2024-07-25 | Valneva Austria Gmbh | Process for virus production in a bioreactor |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
US4761372A (en) | 1981-01-12 | 1988-08-02 | New York University | Mutant enterotoxin of E. coli |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
US4882317A (en) | 1984-05-10 | 1989-11-21 | Merck & Co., Inc. | Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency |
US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
US5308835A (en) | 1984-07-09 | 1994-05-03 | Praxis Biologics, Inc. | Production of the E. coli LT-B enterotoxin subunit |
NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
AUPO264096A0 (en) | 1996-09-30 | 1996-10-24 | Mclaughlin Geosurveys Pty Ltd. | Value improvement of clays |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
CN1142271C (zh) | 1997-08-28 | 2004-03-17 | 第一制糖株式会社 | 适应非洲绿猴肾细胞的减毒的日本脑炎病毒和其疫苗 |
EP1109576B1 (en) | 1998-08-19 | 2009-10-21 | Baxter Healthcare SA | Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
WO2002064162A2 (en) | 2001-02-13 | 2002-08-22 | Government Of The United States, As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
US20110189217A1 (en) * | 2008-06-26 | 2011-08-04 | Barry Michael A | Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
CN101734698B (zh) | 2009-09-08 | 2013-01-09 | 东北大学 | 一种由含铝物料制备氧化铝的方法 |
DK2788023T3 (da) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner |
-
2012
- 2012-12-06 DK DK12795830.4T patent/DK2788023T3/da active
- 2012-12-06 SI SI201231133T patent/SI3106176T1/en unknown
- 2012-12-06 PL PL17185526.5T patent/PL3269386T3/pl unknown
- 2012-12-06 LT LTEP16183076.5T patent/LT3106176T/lt unknown
- 2012-12-06 DK DK16183076.5T patent/DK3106176T3/da active
- 2012-12-06 EP EP16183076.5A patent/EP3106176B1/en not_active Revoked
- 2012-12-06 EP EP20184308.3A patent/EP3785730B1/en active Active
- 2012-12-06 PT PT171855265T patent/PT3269386T/pt unknown
- 2012-12-06 HU HUE16183076A patent/HUE037325T2/hu unknown
- 2012-12-06 DK DK20184308.3T patent/DK3785730T3/da active
- 2012-12-06 ES ES17185526T patent/ES2930458T3/es active Active
- 2012-12-06 EP EP17185526.5A patent/EP3269386B1/en active Active
- 2012-12-06 EP EP12795830.4A patent/EP2788023B1/en active Active
- 2012-12-06 RS RS20171241A patent/RS56709B1/sr unknown
- 2012-12-06 DE DE202012012768.3U patent/DE202012012768U1/de not_active Expired - Lifetime
- 2012-12-06 EP EP24167413.4A patent/EP4400115A3/en active Pending
- 2012-12-06 WO PCT/EP2012/074701 patent/WO2013083726A1/en active Application Filing
- 2012-12-06 PT PT161830765T patent/PT3106176T/pt unknown
- 2012-12-06 ES ES16183076.5T patent/ES2647882T3/es active Active
- 2012-12-06 PL PL16183076T patent/PL3106176T3/pl unknown
- 2012-12-06 FI FIEP20184308.3T patent/FI3785730T3/fi active
- 2012-12-06 NO NO16183076A patent/NO3106176T3/no unknown
- 2012-12-06 DK DK17185526.5T patent/DK3269386T3/da active
-
2013
- 2013-12-09 DK DKBA201300194U patent/DK201300194U1/da not_active Application Discontinuation
- 2013-12-09 DK DKBA201300193U patent/DK201300193U1/da not_active IP Right Cessation
-
2017
- 2017-12-04 HR HRP20171871TT patent/HRP20171871T1/hr unknown
-
2018
- 2018-01-10 CY CY20181100033T patent/CY1119927T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3106176A1 (en) | 2016-12-21 |
HUE037325T2 (hu) | 2018-08-28 |
EP2788023B1 (en) | 2016-11-02 |
EP3106176B1 (en) | 2017-10-11 |
FI3785730T3 (fi) | 2024-05-06 |
NO3106176T3 (da) | 2018-03-10 |
DK3106176T3 (da) | 2018-01-08 |
EP3785730B1 (en) | 2024-04-24 |
DK201300193U1 (da) | 2014-01-17 |
DK2788023T3 (da) | 2016-12-19 |
EP4400115A3 (en) | 2024-10-23 |
DE202012012768U1 (de) | 2014-01-21 |
EP3269386B1 (en) | 2022-09-14 |
EP4400115A2 (en) | 2024-07-17 |
DK201300194U1 (da) | 2014-01-17 |
CY1119927T1 (el) | 2018-12-12 |
SI3106176T1 (en) | 2018-04-30 |
PT3269386T (pt) | 2022-12-05 |
ES2647882T3 (es) | 2017-12-27 |
EP2788023A1 (en) | 2014-10-15 |
EP3269386A1 (en) | 2018-01-17 |
PL3106176T3 (pl) | 2018-03-30 |
DK3785730T3 (da) | 2024-05-06 |
PL3269386T3 (pl) | 2022-12-05 |
HRP20171871T1 (hr) | 2018-01-12 |
EP3785730A1 (en) | 2021-03-03 |
LT3106176T (lt) | 2018-01-10 |
PT3106176T (pt) | 2017-12-20 |
ES2930458T3 (es) | 2022-12-13 |
WO2013083726A1 (en) | 2013-06-13 |
RS56709B1 (sr) | 2018-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3269386T3 (da) | Aluminiumforbindelser til anvendelse inden for behandling og i vacciner | |
DK2925782T3 (da) | Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf | |
DK2428450T3 (da) | Doseringsmetode og doseringsindretning | |
DK2950535T3 (da) | Fremgangsmåde og indretning til at afkode intra-forudsigelsestilstand | |
DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
DK2857401T3 (da) | Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme | |
DK2914627T3 (da) | Anti-cd40-antistoffer og fremgangsmåder til anvendelse | |
DK2734128T3 (da) | Kirurgisk hentningsindretning med halvstift udtrækkelig og sammenklappelig kurv | |
DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
DK3358011T3 (da) | Peptid til inducering af regenerering af væv og anvendelse deraf | |
DK3197164T3 (da) | Afkodningsanordning og afkodningsfremgangsmåde | |
DK2900657T3 (da) | Cykliske etherpyrazol-4-yl-heterocyclyl-carboxamidforbindelser og fremgangsmåder til anvendelse | |
DK2931143T3 (da) | Implantat og føring til kæbe-ansigts-kirurgi | |
DK2854883T3 (da) | Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf | |
DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
DK3045187T3 (da) | Injektor og fremgangsmåde til samling | |
DK2672967T3 (da) | Forbindelser og fremgangsmåder til kinasemodulering og indikationer derfor | |
DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
DK3550836T3 (da) | Fremgangsmåde og anordning til afkodning | |
DK2895607T3 (da) | Dobbeltstrengede oligonukleotidmolekyler til ddit4 og fremgangsmåder til anvendelse deraf | |
BR302012003126S1 (pt) | Configuração aplicada em empunhadura para intrumento médico | |
DK2815769T3 (da) | Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet | |
DK2795210T3 (da) | Køleelement og køleindretning | |
DK2693816T3 (da) | Fremgangsmåde og enhed til brug i rammegenkendelse | |
BR112014020761A2 (pt) | Aparelho médico e método |